Research Profile and Molecular Characteristics
Glycomet 850 mg is a pharmaceutical metformin hydrochloride formulation manufactured by USV Private Ltd., representing the biguanide class of antidiabetic compounds. Metformin hydrochloride (CAS: 657-24-9) demonstrates unique molecular properties with the formula C₄H₁₁N₅·HCl and molecular weight of 165.63 g/mol. This established pharmaceutical preparation provides researchers with standardised access to investigate metabolic modulation pathways and cellular energy regulation mechanisms. The compound’s primary research focus centres on its ability to activate AMP-activated protein kinase (AMPK) pathways, making it valuable for studies into glucose homeostasis, lipid metabolism, and mitochondrial function. Laboratory researchers examining metabolic disorders frequently utilise metformin formulations like Glycomet to explore therapeutic mechanisms and cellular signalling cascades. At Stroid UK Shop, this pharmaceutical-grade preparation offers consistent quality for research applications requiring reliable compound characterisation.
Laboratory Applications in Metabolic Research
Research applications for Glycomet 850 mg span multiple areas of metabolic investigation, particularly in cellular energy studies and glucose regulation research. Scientists examine this biguanide compound’s effects on hepatic gluconeogenesis inhibition, studying how it reduces glucose production in liver cell cultures and tissue models. The compound’s AMPK activation properties make it valuable for investigating cellular energy sensing mechanisms and metabolic pathway regulation. Researchers also explore its effects on insulin sensitivity modulation, examining how metformin influences glucose uptake in muscle and adipose tissue models. Studies into mitochondrial respiratory complex I inhibition provide insights into the compound’s mechanism of action at the cellular level. Academic laboratories frequently incorporate Glycomet preparations into studies examining metabolic syndrome models, obesity research, and aging-related metabolic dysfunction. The pharmaceutical formulation’s consistency enables reproducible experimental protocols across different research institutions. Investigators studying metabolic modulators often compare metformin’s effects with other compounds to understand synergistic mechanisms and pathway interactions.
Product Specifications and Research Standards
| Parameter | Specification |
|---|---|
| Active Ingredient | Metformin Hydrochloride 850 mg |
| Manufacturer | USV Private Ltd. |
| CAS Number | 657-24-9 |
| Molecular Formula | C₄H₁₁N₅·HCl |
| Molecular Weight | 165.63 g/mol |
| Physical Form | Film-coated tablet |
| Storage Conditions | Room temperature, dry place |
| Research Applications | Metabolic studies, AMPK research |
This pharmaceutical preparation offers researchers access to metformin hydrochloride in a standardised tablet formulation, ensuring consistent dosing for experimental protocols. The USV Private Ltd. manufacturing provides pharmaceutical-grade quality assurance, with established production standards that support reproducible research outcomes. Unlike raw powder preparations, the tablet form offers precise compound delivery and simplified handling protocols for laboratory use. Researchers studying metabolic pathways alongside selective androgen receptor modulators can investigate potential interactions between different compound classes and their effects on cellular metabolism.
Research Compliance and Safety Information
Glycomet 850 mg tablets are supplied exclusively for in-vitro research purposes and laboratory studies examining metabolic mechanisms. This pharmaceutical preparation requires appropriate laboratory handling procedures and storage protocols to maintain compound integrity throughout research applications. Investigators should establish proper experimental controls when studying metformin’s effects on cellular cultures, tissue models, and biochemical assays. The compound’s established pharmaceutical profile provides researchers with extensive literature references and characterisation data to support experimental design and protocol development. Storage recommendations include maintaining tablets at room temperature in dry conditions, protecting from moisture and excessive heat exposure. Research facilities should implement appropriate safety protocols when handling pharmaceutical preparations and ensure compliance with institutional guidelines for compound storage and disposal. Studies incorporating metformin research alongside peptide compounds require careful consideration of potential interactions and experimental variables. This product is intended solely for research applications and not for human consumption or therapeutic use.
